A comprehensive meta-analysis by AlKurd et al. [88], encompassing 14 randomized controlled trials up to 2021, confirmed significant improvements in glycated hemoglobin (HbA1c) levels and daily insulin dose reduction following CM supplementation in both T1DM and T2DM patients. This evidence concerns the gene INS and type 1 diabetes mellitus.